K KURA ONCOLOGY INC
| Market Cap | $760.52M |
| P/E Ratio | — |
| Forward P/E | -3.53 |
| Dividend Yield | — |
| Beta | 0.24 |
| 52W Range | $5.54 - $12.14 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Biotechnology |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Polen Capital Management Polen Capital Management | 0.00% | $943.00K | 90,847 | Buy |
Insider Trading
| Insider Name of the company insider who made the trade 22 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Burrows FrancisChief Scientific Officer | Sale | 1,311 | $8.46 | $11.09K | 27 Jan 2026 | 27 Jan 2026 |
| Bair Teresa BrophyChief Legal Officer | Sale | 4,096 | $8.46 | $34.66K | 27 Jan 2026 | 27 Jan 2026 |
| FORD KATHLEENChief Operating Officer | Sale | 1,813 | $8.46 | $15.34K | 27 Jan 2026 | 27 Jan 2026 |
| Bair Teresa BrophyChief Legal Officer | Sale | 4,777 | $8.46 | $40.42K | 27 Jan 2026 | 27 Jan 2026 |
| Bair Teresa BrophyChief Legal Officer | Sale | 2,335 | $8.46 | $19.76K | 27 Jan 2026 | 27 Jan 2026 |
| DOYLE THOMAS JAMESSVP, Finance & Accounting | Sale | 881 | $8.46 | $7.45K | 27 Jan 2026 | 27 Jan 2026 |
| DOYLE THOMAS JAMESSVP, Finance & Accounting | Sale | 695 | $8.46 | $5.88K | 27 Jan 2026 | 27 Jan 2026 |
| DOYLE THOMAS JAMESSVP, Finance & Accounting | Sale | 1,114 | $8.46 | $9.43K | 27 Jan 2026 | 27 Jan 2026 |
| DOYLE THOMAS JAMESSVP, Finance & Accounting | Sale | 2,226 | $8.46 | $18.83K | 27 Jan 2026 | 27 Jan 2026 |
| Leoni MollieChief Medical Officer | Sale | 1,341 | $8.46 | $11.35K | 27 Jan 2026 | 27 Jan 2026 |
| Leoni MollieChief Medical Officer | Sale | 951 | $8.46 | $8.05K | 27 Jan 2026 | 27 Jan 2026 |
| Leoni MollieChief Medical Officer | Sale | 2,233 | $8.46 | $18.89K | 27 Jan 2026 | 27 Jan 2026 |
| Leoni MollieChief Medical Officer | Sale | 3,655 | $8.46 | $30.92K | 27 Jan 2026 | 27 Jan 2026 |
| Powl Brian T.Chief Commercial Officer | Sale | 1,572 | $8.46 | $13.30K | 27 Jan 2026 | 27 Jan 2026 |
| Powl Brian T.Chief Commercial Officer | Sale | 4,842 | $8.46 | $40.97K | 27 Jan 2026 | 27 Jan 2026 |
| Burrows FrancisChief Scientific Officer | Sale | 23,726 | $9.78 | $231.93K | 18 Dec 2025 | 19 Dec 2025 |
| Hasnain Faheem | Sale | 10,000 | $10.98 | $109.76K | 09 Dec 2025 | 10 Dec 2025 |
| Powl Brian T.Chief Commercial Officer | Sale | 8,887 | $11.18 | $99.33K | 14 Nov 2025 | 14 Nov 2025 |
| Leoni MollieChief Medical Officer | Sale | 15,485 | $11.18 | $173.07K | 14 Nov 2025 | 14 Nov 2025 |
| FORD KATHLEENChief Operating Officer | Sale | 6,902 | $11.18 | $77.14K | 14 Nov 2025 | 14 Nov 2025 |
| DOYLE THOMAS JAMESSVP, Finance & Accounting | Sale | 4,539 | $11.18 | $50.73K | 14 Nov 2025 | 14 Nov 2025 |
| Bair Teresa BrophyChief Legal Officer | Sale | 8,804 | $11.18 | $98.40K | 14 Nov 2025 | 14 Nov 2025 |
Frequently Asked Questions
What is KURA stock price today?
KURA ONCOLOGY INC (KURA) is currently trading at $8.61. The stock has a 52-week range of $5.54 to $12.14 and a market capitalization of $760.52M.
Is KURA a good stock to buy in 2026?
KURA ONCOLOGY INC has a P/E ratio of N/A (forward P/E: N/A), a dividend yield of none, and 1-year performance of +39.5%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling KURA stock?
There have been 22 insider transactions for KURA in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has KURA stock performed over the past year?
KURA ONCOLOGY INC (KURA) has returned +39.5% over the past 12 months. The stock traded between $5.54 and $12.14 during this period, and is currently at $8.61.
Which hedge funds own KURA (KURA ONCOLOGY INC)?
1 tracked hedge funds currently hold KURA in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is KURA's market cap and valuation?
KURA ONCOLOGY INC (KURA) has a market capitalization of $760.52M. The trailing P/E ratio is N/A and forward P/E is N/A. The stock is classified in the Healthcare sector.
What is KURA's revenue and profitability?
KURA ONCOLOGY INC reported revenue of $67.48M with net income of N/A and a profit margin of N/A. The stock has a beta of 0.24.
What sector is KURA in and who are its biggest institutional holders?
KURA ONCOLOGY INC (KURA) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.